Baxter Says Deaths Unrelated To Heparin Quality

NEW YORK (AP) — Baxter International Inc. said Friday two patient deaths in a Delaware hospital, along with a third case of cerebral hemorrhage, were unrelated to the quality of its blood-thinner heparin.

Earlier this month, the Food and Drug Administration said it was investigating the deaths of two Delaware hospital patients who were given heparin. In all, three patients suffered cerebral hemorrhages. Officials at Beebe Medical Center in Lewes, Del. reported the adverse reactions.

Baxter said it and the FDA launched a "comprehensive" investigation following the reports. ...